文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

包膜切除术、假体置换和脱细胞真皮基质的应用在治疗隆胸患者包膜挛缩中是有效的。

Capsulectomy, Implant Exchange, and Placement of Acellular Dermal Matrix Is Effective in Treating Capsular Contracture in Breast Augmentation Patients.

机构信息

Northeast Ohio Medical University, Akron, OH, USA.

出版信息

Aesthet Surg J. 2021 Feb 12;41(3):304-312. doi: 10.1093/asj/sjz358.


DOI:10.1093/asj/sjz358
PMID:31826242
Abstract

BACKGROUND: Capsular contracture is a common complication of breast augmentation surgery and many techniques to prevent and treat it have been suggested with inconsistent or variably effective results. OBJECTIVES: The aim of this paper was to describe a protocol for treating established capsular contracture after breast augmentation with a low recurrence rate. METHODS: From January 2009 to December 2012, 79 previous bilateral breast augmentation patients presented for treatment of established capsular contracture. There were 135 breasts with capsular contracture: 56 were bilateral and 23 were unilateral. Ten patients opted for no treatment; 2 patients opted for implant removal. Twenty-four were treated with the ICES (implant exchange, capsulectomy, and possible exchange of site) protocol and 43 were treated with the SPICES (Strattice placement in the reconstructive position, implant exchange, capsulectomy, and possible exchange of site) protocol. RESULTS: The 24 patients treated with the ICES protocol had a recurrent capsular contracture rate of 15%. The 43 patients treated with the SPICES protocol had a 2.7% recurrent capsular contracture incidence and an 2.7% complication rate. CONCLUSIONS: Capsular contracture after breast augmentation, whether primary or recurrent, can be successfully treated with the SPICES protocol.

摘要

背景:包膜挛缩是乳房隆乳术的常见并发症,已经提出了许多预防和治疗包膜挛缩的技术,但结果不一致或效果不同。

目的:本文旨在描述一种治疗乳房隆乳术后已形成的包膜挛缩的方案,以降低其复发率。

方法:从 2009 年 1 月至 2012 年 12 月,79 例双侧乳房隆乳术的既往患者因已形成的包膜挛缩而就诊。共有 135 个乳房有包膜挛缩:56 个为双侧,23 个为单侧。10 例患者选择不治疗;2 例患者选择取出植入物。24 例患者采用 ICEs(植入物交换、包膜切除术和可能的植入物位置交换)方案治疗,43 例患者采用 SPICES(Strattice 在重建位置的放置、植入物交换、包膜切除术和可能的植入物位置交换)方案治疗。

结果:采用 ICEs 方案治疗的 24 例患者中,包膜挛缩复发率为 15%。采用 SPICES 方案治疗的 43 例患者中,包膜挛缩复发率为 2.7%,并发症发生率为 2.7%。

结论:乳房隆乳术后的包膜挛缩,无论是原发性还是复发性,都可以通过 SPICES 方案成功治疗。

相似文献

[1]
Capsulectomy, Implant Exchange, and Placement of Acellular Dermal Matrix Is Effective in Treating Capsular Contracture in Breast Augmentation Patients.

Aesthet Surg J. 2021-2-12

[2]
Efficacy of Acellular Dermal Matrix Type in Treatment of Capsular Contracture in Breast Augmentation: A Systematic Review and Meta-Analysis.

Aesthet Surg J. 2023-12-14

[3]
Commentary on: Capsulectomy, Implant Exchange, and Placement of Acellular Dermal Matrix is Effective in Treating Capsular Contracture in Breast Augmentation Patients.

Aesthet Surg J. 2021-2-12

[4]
Use of dermal matrix to prevent capsular contracture in aesthetic breast surgery.

Plast Reconstr Surg. 2012-11

[5]
Risk Factors for Capsular Contracture in Alloplastic Reconstructive and Augmentation Mammaplasty: Analysis of the National Surgical Quality Improvement Program (NSQIP) Database.

Aesthetic Plast Surg. 2023-10

[6]
Treatment of capsular contracture using complete implant coverage by acellular dermal matrix: a novel technique.

Plast Reconstr Surg. 2013-9

[7]
Revisiting the Management of Capsular Contracture in Breast Augmentation: A Systematic Review.

Plast Reconstr Surg. 2016-3

[8]
Systematic Review of Capsular Contracture Management following Breast Augmentation: An Update.

Plast Reconstr Surg. 2024-2-1

[9]
Efficacy of Acellular Dermal Matrix in Capsular Contracture of Implant-Based Breast Reconstruction: A Single-Arm Meta-analysis.

Aesthetic Plast Surg. 2020-6

[10]
Use of porcine acellular dermal matrix in revisionary cosmetic breast augmentation.

Aesthet Surg J. 2013-7

引用本文的文献

[1]
Capsular Contracture After Breast Augmentation: Our Approach to Prevent Reoccurrence with Combined Total Capsulectomy and Implantation of Motiva Ergonomix® Implants.

Aesthetic Plast Surg. 2025-4

[2]
A Comparison of Ovine-Reinforced Hybrid Mesh (OviTex PRS) With Porcine Acellular Dermal Matrix (STRATTICE) in the Treatment of Advanced Breast Implant Capsular Contracture.

Aesthet Surg J Open Forum. 2024-8-20

[3]
National trends in revision procedures in post-mastectomy breast reconstruction: Autologous vs implant-based approaches.

J Plast Reconstr Aesthet Surg. 2024-8

[4]
Revision Breast Reconstruction With Biologic or Synthetic Mesh: An Analysis of Postoperative Capsular Contracture Rates.

Aesthet Surg J Open Forum. 2024-5-16

[5]
Acellular dermal matrix in breast augmentation surgery: A systematic review.

JPRAS Open. 2024-2-15

[6]
A feasibility study assessing quantitative indocyanine green angiographic predictors of reconstructive complications following nipple-sparing mastectomy.

JPRAS Open. 2024-1-26

[7]
A Safe and Effective Alternative to Acellular Dermal Matrix in the Treatment of Capsular Contracture of the Breast.

Ann Plast Surg. 2024-2-1

[8]
Advances on Capsular Contracture-Prevention and Management Strategies: A Narrative Review of the Literature.

Plast Reconstr Surg Glob Open. 2023-6-9

[9]
Peer Review: How to Review a Plastic Surgery Manuscript.

Ann Plast Surg. 2023-4-1

[10]
Does Acellular Dermal Matrix Really Reduce the Risk of Recurrent Ptosis after Mastopexy?

Plast Reconstr Surg Glob Open. 2022-8-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索